Hanmi Pharmaceutical, a Korean R&D-centric biopharmaceutical company, has adopted Microsoft 365 Copilot and Surface Copilot+ PCs as part of its company-wide AI transformation initiative.
By implementing an AI PC environment, the company is simultaneously enhancing productivity and security. Deploying Surface devices to sales teams has enabled real-time, cloud-based data access and input in the field.
Hanmi's AI transformation began with a PoC in 2024. With Microsoft 365 Copilot, workflow integration and efficiency improved. The company aims to develop AI agents through Copilot Studio and Azure AI Foundry.
Follow Microsoft